Male pattern hair loss: current understanding.
Whiting
D A
DA
Department of Dermatology, The University of Texas, Southwestern Medical Center at Dallas, and the Baylor Hair Research and Treatment Center, USA.
D000505:Alopecia / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology / Q000503:physiopathology; D042944:Cholestenone 5 alpha-Reductase; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D018120:Finasteride / Q000627:therapeutic use; D018859:Hair Follicle / Q000201:enzymology; D006801:Humans; D008297:Male; D010088:Oxidoreductases / Q000037:antagonists & inhibitors / Q000378:metabolism
D004791:Enzyme Inhibitors; D018120:Finasteride; D010088:Oxidoreductases; D042944:Cholestenone 5 alpha-Reductase